Iridex Corporation announced the publication of a significant peer-reviewed study in Ophthalmology Therapy, demonstrating the long-term safety and efficacy of MicroPulse Transscleral Laser Therapy ...
Please provide your email address to receive an email when new articles are posted on . A 52-year-old startup CEO presented in January 2021 with distortion in the right eye. He had a large subfoveal ...
Please provide your email address to receive an email when new articles are posted on . A study investigated subthreshold MicroPulse laser therapy for center-involved diabetic macular edema. The ...
MicroPulse ® Transscleral Laser Therapy (TLT), continuous-wave transscleral cyclophotocoagulation (CW-TSCPC), and MicroPulse Laser Trabeculoplasty (MLT) are non-incisional treatments that expand ways ...
Iridex (IRIX) announced a recently published independent, retrospective study in Ophthalmology and Therapy. The study demonstrates that retreatment of transscleral laser treatment using MicroPulse ...
MOUNTAIN VIEW, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (IRIX), headquartered in Mountain View, California, and Imperial College Healthcare NHS Trust in London, today announced the ...
Glaucoma is usually a chronic condition associated with raised intraocular pressure. The most common type of glaucoma in the UK is primary (or chronic) open-angle glaucoma. It leads to progressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results